SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001193125-16-597726
Filing Date
2016-05-20
Accepted
2016-05-20 17:02:15
Documents
8

Document Format Files

Seq Description Document Type Size
1 FORM F-3 d193702df3.htm F-3 347155
2 EX-5.1 d193702dex51.htm EX-5.1 21553
3 EX-8.1 d193702dex81.htm EX-8.1 15038
4 EX-23.1 d193702dex231.htm EX-23.1 3716
5 GRAPHIC g193702g93x08.jpg GRAPHIC 39004
6 GRAPHIC g193702img01.jpg GRAPHIC 21298
7 GRAPHIC g193702img02.jpg GRAPHIC 5224
8 GRAPHIC g193702img03.jpg GRAPHIC 21298
  Complete submission text file 0001193125-16-597726.txt   508486
Mailing Address TUBORG BOULEVARD 5 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 5 HELLERUP G7 DK-2900 45 36 94 44 86
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-211511 | Film No.: 161667050
SIC: 2834 Pharmaceutical Preparations